“We Can Do This!” from the National Consumers League, a nonprofit with a 120+ year history advocating for consumers on marketplace and workplace issues.
In each episode, we talk through some of the major cultural issues and public policy battles of today with individuals helping to shape our nation’s social and economic reforms in health, data and privacy, food and nutrition, labor, and finance.
Hosted by NCL Chief Executive Officer Sally Greenberg and NCL’s senior policy staff.
Send inquiries and questions to:
info@nclnet.org
In this episode of NCL’s “We Can Do This” podcast, we dive into the world of biosimilars—cost-effective alternatives to expensive biologic drugs. Host Sally welcomes Giuseppe Randazzo (Association for Accessible Medicines) and Anna Hyde (Arthritis Foundation) to discuss the urgent need to simplify the biosimilar approval process. Discover how regulatory modernization could save billions, improve patient access, and break down barriers in the healthcare system.
Our experts explain the challenges patients face, the importance of building trust in biosimilars, and the legislative changes needed to ensure safe, effective, and affordable treatments for all. Tune in for actionable insights and real-world stories that matter to patients, providers, and policymakers alike.
